Hanoi Department of Health has just issued a letter to medical facilities in the area;Department of Health of districts, towns and towns;Central Pharmaceutical Joint Stock Company 2;Gia Hung Pharmaceutical Trading Company Limiteddrug recoveryRotunda does not meet quality standards.
Accordingly, implementing Official Letter No. 13011/QLD-CL dated 06/12/2022 of the Drug Administration of Vietnam on the sample of Rotunda drugs does not meet quality standards.Department of Health notified the recovery of Rotunda tablets (Rotundin 30mg), SDK: VD-33576-19, lot: 01522, NSX: 10/10/2022, HD: 10/10/2025, Pharmacy Joint Stock CompanyCentral products 2 produced.The drug sample does not meet the quality standards of related impurities (violating level 2).
Illustration.
Hanoi Department of Health asked the Director of Central Pharmaceutical Joint Stock Company 2;Gia Hung Pharmaceutical Trading Co., Ltd. thoroughly recovered Rotunda (Rotundin 30mg), SDK: VD-33576-19, lot: 01522 does not meet quality standards in Hanoi and sutrasBusiness and use of medicine lots provided by Gia Hung Pharmaceutical Trading Co., Ltd;Send recovery reports and recall documents as prescribed in Official Letter No. 13011/QLD-CL.The Department of Health will check and supervise the recovery of the units.
Public health facilities, non -public health facilities, businesses and retailing drugs in Hanoi city urgently review and recover the above -mentioned drug lots of drug standards.
The Health Department of districts, towns and towns informs the practicing establishments in the area to manage, conduct inspection and supervision of the recovery implementation of the establishment (if any).At the same time, the Hanoi Center for Disease Control posted information and coordinated with communication agencies to information to business establishments, use drugs and people know not to trade.
On December 13, Hanoi Department of Health issued Official Letter No. 5636/SYT-NVD on the recall of drug circulation registration papers in Vietnam to medical facilities in the area;Health Departments of districts, towns.Official letter stated that the implementation of Decision No. 755/QD-QLD dated November 24, 2022 of the Drug Administration of Vietnam on recovery of the drug circulation registration certificate in Vietnam for Navacarzol medicine was granted a circulation registration certificateVN-17813-14.The Department of Health announces the recovery of all Navacarzol drug lots registration number VN-17813-14 according to Decision No. 755/QD-QLD.
The Department of Health proposed public health facilities under the industry, non -public health facilities, drug trading enterprises, drug retail establishments in the area to urgently review and recover all.Lot medicine under Decision No. 755/QD-QLD;send recovering reports and recall documents according to regulations to the Department of Health and Drug Administration of Vietnam.The Health Department of districts, towns and towns informs the practicing establishments in the area to manage, conduct inspection and supervision of the recovery of the establishment.The Director of the Hanoi Center for Drugs, Cosmetics and Food Testing reviews during the sampling process, reporting to the Department of Health (Department Inspectorate) for handling measures.